Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Breast Cancer Res Treat. 2021 Jun 26;189(1):187–202. doi: 10.1007/s10549-021-06307-3

Table 1.

Characteristics of study population

Total study population (%) Non-pCR N=69 (%) pCR N=58 (%) p value
Age at diagnosis, median (IQR) 52.5 (42-61) 53.0 (44.0-62.0) 51.5 (40.2-58.8) 0.301
Race
Caucasian
Black
Other
98 (74.2)
31 (23.5)
3 (2.3)
49 (71.0)
18 (26.1)
2 (2.9)
44 (75.9)
13 (22.4)
1 (1.7)


0.913
Clinical stage
II
III
107 (81.1)
25 (18.9)
54 (78.3)
15 (21.7)
48 (82.8)
10 (17.2)

0.648
Tumor grade
II
III
9 (6.8)
123 (93.2)
7 (10.1)
62 (89.9)
2 (3.5)
56 (96.5)

0.179
Clinical node status
Positive
Negative
58 (43.9)
74 (56.1)
34 (49.3)
35 (50.7)
22 (37.9)
36 (62.1)

0.301